10x Genomics, Inc. (TXG) Profit Margins
Over the twelve months to 2026-06-30, 10x Genomics, Inc. (TXG) had gross margin 70.0%, operating margin -14.3%, net margin -12.2%, free cash flow margin 19.7%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TXG10x Genomics, Inc.Follow TXG — free
—
Price chart with a free account
- Market cap
- 9.3B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 5 Nov, in 12 days
| Line | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 75.2% | 80.4% | 84.9% | 76.7% | 66.2% | 67.9% | 69.1% | 70.0% | |
| Operating margin | -12.4% | -178.7% | -10.7% | -32.5% | -42.9% | -31.9% | -9.5% | -14.3% | |
| Net margin | -12.7% | -181.6% | -11.9% | -32.1% | -41.2% | -29.9% | -6.8% | -12.2% | |
| FCF margin | -3.3% | -85.2% | -25.0% | -32.0% | -10.3% | -0.9% | 20.2% | 19.7% |
USD billions · SEC XBRL
10x Genomics, Inc. — questions
- What is 10x Genomics, Inc.'s gross margin?
- 70.0% over the twelve months to 2026-06-30.
- What is 10x Genomics, Inc.'s operating margin?
- -14.3% over the twelve months to 2026-06-30.
- What is 10x Genomics, Inc.'s net profit margin?
- -12.2% over the twelve months to 2026-06-30.
Every figure on this page comes from 10x Genomics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.